IL-9 promotes anti-Mycobacterium leprae cytotoxicity: Involvement of IFNγ

Clinical and Experimental Immunology

Volumn 147, Issue 1, 2007, Pages 139-147

  Finiasz, M R ^c   Franco, M C ^a,c   De La Barrera, S ^c   Rutitzky, L ^b,c   Pizzariello, G ^d   Del Carmen Sasiain, M ^c   Renauld, J C ^e   Van Snick, J ^e   Fink, S ^c  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INST DE INVEST HEMATOLOGICAS   (Argentina)

^d HOSPITAL F J MUÑIZ   (Argentina)

^e UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Cytokines; Leprosy patients; PBMC

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 9; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY GAMMA INTERFERON; OKT 4; OKT 8; THALIDOMIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DRUG EFFECT; DRUG POTENTIATION; FEMALE; HUMAN; HUMAN CELL; LEPROSY; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM LEPRAE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH2 CELL;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HUMANS; IMMUNIZATION; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-13; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-6; INTERLEUKIN-9; LEPROSY; MACROPHAGES; MALE; MIDDLE AGED; MYCOBACTERIUM LEPRAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES;

EID: 33845497542     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03241.x     Document Type: Article

References (30)

1. Renauld J-C, Goethals A, Houssiau F, Van Roost E, Van Snick J. Cloning and expression of a cDNA for the human homolog of mouse T-cell and mast cell growth factor P40. Cytokine 1990; 2:9-12.
2. Macaubas C, Sly PD, Burton P et al. Regulation of T helper cell responses to inhalant allergen during early childhood. Clin Exp Allergy 1999; 29:1223-31.
3. Jenmalm MC, Van Snick J, Cormont F, Salman B. Allergen-induced Th1 and Th2 cytokine secretion in relation to specific allergen sensitization and atopic symptoms in children. Clin Exp Allergy 2001; 31:1528-35.
4. Turner JD, Faulkner H, Kamgno J et al. Th2 cytokines are associated with reduced worm burdens in a human intestinal helminth infection. J Infect Dis 2003; 188:1768-75.
5. Gessner A, Blum H, Röllinghoff M. Differential regulation of IL-9 expression after infection with Leishmania major in susceptible and resistant mice. Immunobiol 1993; 189:419-35.
6. Arendse B, Van Snick J, Brombacher F. IL-9 is a susceptibility factor in Leishmania major infection by promoting detrimental Th2/type 2 responses. J Immunol 2005; 174:2205-11.
7. Grohmann U, Van Snick J, Campanile F et al. IL-9 protects mice from Gram-negative bacterial shock: suppression of TNF-alpha, IL-12, and IFN-gamma, and induction of IL-10. J Immunol 2000; 164:4197-203.
8. Arras M, Huaux F, Vink A et al. Interleukin-9 reduces lung fibrosis and type 2 immune polarization induced by silica particles in a murine model. Am J Respir Cell Mol Biol 2001; 24:368-75.
9. Ridley DS, Jopling WH. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis 1966; 34:255-73.
10. Sasiain MC, de la Barrera S, Minnucci F, Valdez R, de Elizalde de Bracco MM, Balina LM. T-cell-mediated cytotoxicity against Mycobacterium antigen-pulsed autologous macrophages in leprosy patients. Infect Immun 1992; 60:3389-95.
11. Mutis T, Cornelisse YE, Ottenhoff TH. Mycobacteria induce CD4+ T cells that are cytotoxic and display Th1-like cytokine secretion profile: heterogeneity in cytotoxic activity and cytokine secretion levels. Eur J Immunol 1993; 23:2189-95.
12. de la Barrera S, Fink S, Finiasz M et al. Lack of cytotoxic activity against Mycobacterium leprae 65-kD heat shock protein (hsp) in multibacillary leprosy patients. Clin Exp Immunol 1995; 99:90-7.
13. Fink S, de la Barrera S, Minnucci F, Valdez R, Balina LM, Sasiain MC. IFN-gamma IL-6 and IL-4 modulate M. leprae- or PPD-specific cytotoxic T cells in leprosy patients. Scand J Immunol 1993; 38:551-8.
14. Aleman M, De La Barrera S, Fink S et al. Interleukin-12 amplifies the M. leprae hsp65-cytotoxic response in the presence of tumour necrosis factor-alpha and interferon-gamma generating CD56+ effector cells: interleukin-4 downregulates this effect. Scand J Immunol 2000; 51:262-70.
15. Canaday DH, Wilkinson RJ, Li Q, Harding CV, Silver RF, Boom WH. CD4(+) and CD8(+) T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism. J Immunol 2001; 167:2734-42.
16. Louahed J, Kermouni A, Van Snick J, Renauld JC. IL-9 induces expression of granzymes and high-affinity IgE receptor in murine T helper clones. J Immunol 1995; 154:5061-70.
17. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Laboratory Invest Suppl 1968; 97:77-89.
18. Gray PW, Leung DW, Pennica D et al. Expression of human immune interferon cDNA in E. coli and monkey cells. Nature 1982; 295:503-8.
19. Devos R, Cheroutre H, Taya Y, Degrave W, Van Heuverswyn H, Fiers W. Molecular cloning of human immune interferon cDNA and its expression in eukaryotic cells. Nucl Acids Res 1982; 10:2487-501.
20. Sasiain MC, de la Barrera S, Fink S et al. Interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) are necessary in the early stages of induction of CD4 and CD8 cytotoxic T cells by Mycobacterium leprae heat shock protein (hsp) 65 kD. Clin Exp Immunol 1998; 114:196-203.
21. de la Barrera S, Finiasz M, Fink S et al. NK cells modulate the cytotoxic activity generated by Mycobacterium leprae-hsp65 in leprosy patients: role of IL-18 and IL-13. Clin Exp Immunol 2004; 135:105-13.
22. Dugas B, Renauld JC, Pene J et al. Interleukin-9 potentiates the interleukin-4-induced immunoglobulin (IgG, IgM and IgE) production by normal human B lymphocytes. Eur J Immunol 1993; 23:1687-92.
23. Louahed J, Renauld JC, Demoulin JB et al. Differential activity of dexamethasone on IL-2-, IL-4-, or IL-9-induced proliferation of murine factor-dependent T cell lines. J Immunol 1996; 156:3704-10.
24. de Waal Malefyt R, Abrams JS, Zurawski SM et al. Differential regulation of IL-13 and IL-4 production by human CD8+ and CD4+ Th0, Th1 and Th2 T cell clones and EBV-transformed B cells. Int Immunol 1995; 7:1405-16.
25. Devos S, Cormont F, Vrtala S, Hooghe-Peters E, Pirson F, Snick J. Allergen-induced interleukin-9 production in vitro: correlation with atopy in human adults and comparison with interleukin-5 and interleukin-13. Clin Exp Allergy 2006; 36:174-82.
26. Houssiau FA, Renauld JC, Stevens M et al. J.Human T cell lines and clones respond to IL-9. J Immunol 1993; 150:2634-40.
27. Renauld JC. New insights into the role of cytokines in asthma. J Clin Pathol 2001; 54:577-89.
28. Cheng G, Arima M, Honda K et al. Anti-interleukin-9 antibody treatment inhibits airway inflammation and hyperreactivity in mouse asthma model. Am J Respir Crit Care Med 2002; 166:409-16.
29. Fallon PG, Smith P, Richardson EJ et al. Expression of interleukin-9 leads to Th2 cytokine-dominated responses and fatal enteropathy in mice with chronic Schistosoma mansoni infections. Infect Immun 2000; 68:6005-11.
30. Khan WI, Richard M, Akiho H et al. Modulation of intestinal muscle contraction by interleukin-9 (IL-9) or IL-9 neutralization: correlation with worm expulsion in murine nematode infections. Infect Immun 2003; 71:2430-8.